Abstract
Objective
To analyze the prevalence of sarcopenia in elderly care homes using the algorithm of the European Working Group on Sarcopenia in Older People (EWGSOP) and to evaluate the applicability, sensitivity, and specificity of two simplified algorithms that do not include gait speed measurement.
Design
Cross-sectional study.
Setting
Long-term care homes.
Participants
249 residents (187 females and 62 males) with a mean age of 84.9 ± 6.7 years (range, 70–106 yrs).
Measurements
Cognitive impairment was evaluated with the Pfeiffer test, functional capacity with the Barthel index, walking ability by the Functional Ambulation Classification, muscle mass by bioelectrical impedance analysis, muscle strength by handgrip dynamometry and, gait speed over a distance of 4 m. Sarcopenia was assessed using the EWGSOP-recommended algorithm and two simplified algorithms (A and B). Algorithms A and B were validated with respect to the EWGSOP algorithm using the MacNemar test and obtaining the sensitivity and specificity, kappa coefficient, and area under the receiver operating characteristic curve (AUC).
Results
Total or severe dependence was recorded in 67% of the 249 residents, severe or moderate cognitive impairment in 64%, inability to walk in 49%, and capacity to walk only with the aid of an ambulator or two people in 21%. The prevalence of sarcopenia was 63.0% by the EWGSOP algorithm, 62.9% by algorithm A and 63.2% by algorithm B (P = 1.000); 143 participants were diagnosed with sarcopenia by all three methods (P =1.000, K = 1.000).
Conclusion
Further studies that include residents with functional and/or cognitive impairment are required to validate these results, comparing the diagnostic performance of the EGWSOP algorithm with that of the simplified algorithms validated in the present report.
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010;39(4):412–23
Malafarina V, Uriz-Otano F, Gil-Guerrero L et al. Nutritional assessment and treatment of sarcopenia. Rev Esp Geriatr Gerontol 2013;48: 153–154
Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS). Age Ageing 2014;43(6):48–759
Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 2017;12(1):e0169548
Ethgen O, Beaudart C, Buckinx F, Bruyere O, Reginster JY. The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 2017;100(3):229–34
González-Montalvo JI, Alarcón T, Gotor P et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016;16(9):1021–7
Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, Brombo G, Zuliani G, Guralnik JM, Landi F, Volpato S. The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2016;71(2):259–64
Bianchi L, Abete P, Bellelli G et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci 2017; 72(11):1575–81
Yoshida D, Suzuki T, Shimada H et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014;14(Suppl.1):46–51
Manatunga AK, Hudgens M & Chen S. Sample size estimation in cluster randomized studies with varying cluster size. Control Clin Trials 1998;43:75–86
Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired: reliability and meaningfulness. Phys Ther 1984;64:35–40.
Berral de la Rosa F & Del Águila-Quirós D. Nutritional / anthropometric assessment of patients staying in bed or at hospital. Arch Med del Deport 2002;19(88):129–35
Masanes F, Culla A, Navarro-Gonzalez M, Navarro-Lopez M, Sacanella E, Torres B, López-Soto A. Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J Nutr Health Aging 2012;16(2):184–7
Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89(2):465–71.
Ruiz-Ruiz J, Mesa JL, Gutiérrez A, Castillo MJ. Hand size influences optimal grip span in women but not in men. J Hand Surg Am 2002;27(5):897–901
Díaz-Muñoz GA, Cárdenas-Zuluaga DM, Mesa-Jiménez A. Consistency of Mini Nutritional Assessment to identify sarcopenia in older adults in nursing homes in Bogota, Colombia. Nutr Hosp 2015;32(1):270–4
Rahman TTA, Farid HM, Elkholy NM, Mortagy AK. Prevalence of sarcopenia among nursing home older residents in Cairo, Egypt. Adv Aging Res 2014;43(4):118–23
Saka B, Ozkaya H, Karisik E et al. Malnutrition and sarcopenia are associated with increased mortality rate in nursing home residents: a prospective study. Eur Geriatr Med 2016;7(3):232–8
Salvà A, Serra-Rexach JA, Artaza I el al. Prevalence of sarcopenia in Spanish nursing homes: comparison of the results of the ELLI study with other populations. Rev Esp Geriatr Gerontol 2016;51(5):260–4
Sarabia-Cobo CM, Pérez-Rugosa V, Hermosilla-Grijalbo C, Núñez-García MJ, De-Lorena-Quintal P. Prevalencia de sarcopenia en mayores con demencia institucionalizados. Metas Enferm 2015;18(6):17–21
Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JWL. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas 2015;82(4):418–23
Steffl M, Musalek M, Kramperova V, Petr M, Kohlikova E, Holmerova I, Volicer L. Assessment of diagnostics tools for sarcopenia severity using the item response theory (IRT). J Nutr Health Aging 2016;20(10):1051–5
Yalcin A, Aras S, Atmis V, Cengiz OK, Varli M, Cinar E, Atli T. Sarcopenia prevalence and factors associated with sarcopenia in older people living in a nursing home in Ankara Turkey. Geriatr Gerontol Int 2016;16(8):903–10
Landi F, Liperoti R, Fusco D et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci 2012;67(1):48–55
Bijlsma AY, Meskers CG, Ling CH et al. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Omaha) 2013;35: 871–881
Vasconcelos KS, Dias JM, Bastone A et al. Handgrip strength cutoff points to identify mobility limitation in community-dwelling older people and associated factors. J Nutr Health Aging 2016;20(3):306–15
Masanés F, Rojano I, Luque X et al. Cut-off points for muscle mass — not grip strength or gait speed — determine variations in sarcopenia prevalence. J Nutr Health Aging 2017;21(7):825–829
Legrand D, Vaes B, Matheï C, Swine C, Degryse JM. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 2013;42(6):727–34
Mijnarends DM, Meijers JM, Halfens R.J et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc 2013;14(3):170–8
Sayer, AA. Sarcopenia the new geriatric giant: Time to translate research findings into clinical practice. Age Ageing 2014;43: 736–737.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodriguez-Rejon, A.I., Artacho, R., Puerta, A. et al. Diagnosis of Sarcopenia in Long-Term Care Homes for the Elderly: The Sensitivity and Specificity of Two Simplified Algorithms with Respect to the EWGSOP Consensus. J Nutr Health Aging 22, 796–801 (2018). https://doi.org/10.1007/s12603-018-1004-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-018-1004-x